Key Takeaways
- • Delaware Chancery Court rejected founder Suresh Katta's $67.5 million earnout claim tied to Carlyle Group's 2021 investment in clinical data company Saama Technologies, finding he acted in bad faith.
- • The court ordered Katta to pay Saama approximately $7.3 million, reversing the earnout payout direction and imposing financial penalties for misconduct.
- • The ruling centered on Katta's alleged strategy of pushing business contracts that damaged Saama's operations to artificially inflate his earnout entitlement.
- • The decision underscores judicial scrutiny of founder behavior in private equity-backed transactions and earnout dispute resolution in M&A contexts.
Summary
This dispute stems from Carlyle Group's 2021 investment in Saama, a clinical data company. Earnout provisions, which tie founder or management compensation to post-acquisition performance metrics, are common in private equity transactions but frequently become sources of litigation when parties dispute whether contractual milestones have been genuinely met. The Chancery Court's finding of bad faith conduct is a particularly severe determination, suggesting that Katta's actions went beyond legitimate business disagreement into deliberate value destruction for personal gain.
The reversal of the earnout claim—from a $67.5 million receipt to a $7.3 million payment obligation—represents a swing of approximately $75 million in financial exposure for the founder and demonstrates the high stakes involved in earnout disputes at this scale. The ruling carries implications for how courts evaluate founder incentive alignment in private equity transactions and the legal remedies available when founders act against company interests to extract contractual payouts.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.